Check out all the latest news from SENS Research Foundation in our June newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The 2015 Summer Scholars Program has begun with 16 students at 7 prestigious institutions around the US and 1 in the UK. Check the SRF Education Blog to learn more about each scholar and the research s/he will be conducting.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, is among the five TED speakers interviewed by Guy Raz on the latest episode of NPR's lively TED Radio Hour: "The Fountain of Youth".

CCTV America’s Mark Niu sat down with SENS Research Foundation executives Mike Kope and Dr. Aubrey de Grey, to find out more about the SENS Research approach to preventing age-related disease.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, was recently interviewed regarding our work for the Joe Rogan Experience podcast.

Continuing our series of introductory scientific animations, narrator Edward James Olmos introduces the role of mitochondrial DNA damage in aging, and explains SRF’s preventative therapy for the diseases caused by such damage.

Our Rejuvenation Biotechnology 2015 Media Kit includes the latest conference brochure, regularly updated as we confirm additional world-class speakers. Members of the press can also find details here on how to request passes to cover the event.

In this new addition to our series of introductory animations, actor Edward James Olmos explains the role of telomeres in preventing the earliest stages in the development of cancer – a potent existing defence mechanism that SRF is working to reinforce.

SENS Research Foundation scientists Dr. Haroldo Silva and David Halvorsen, working on the "Alternative Lengthening of Telomeres" (ALT) pathway, collaborate with its discoverer Dr. Jeremy Henson to review its role in promoting some of the most deadly cancers.

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

SRF-funded researchers at Albert Einstein College of Medicine have published a new method for quantifying epigenetic mutations at the single cell level, enabling precise studies of aging-induced intercellular variation in the epigenome.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.

Check out all the latest news from SENS Research Foundation in our June newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The 2015 Summer Scholars Program has begun with 16 students at 7 prestigious institutions around the US and 1 in the UK. Check the SRF Education Blog to learn more about each scholar and the research s/he will be conducting.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, is among the five TED speakers interviewed by Guy Raz on the latest episode of NPR's lively TED Radio Hour: "The Fountain of Youth".

CCTV America’s Mark Niu sat down with SENS Research Foundation executives Mike Kope and Dr. Aubrey de Grey, to find out more about the SENS Research approach to preventing age-related disease.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, was recently interviewed regarding our work for the Joe Rogan Experience podcast.

Continuing our series of introductory scientific animations, narrator Edward James Olmos introduces the role of mitochondrial DNA damage in aging, and explains SRF’s preventative therapy for the diseases caused by such damage.

Our Rejuvenation Biotechnology 2015 Media Kit includes the latest conference brochure, regularly updated as we confirm additional world-class speakers. Members of the press can also find details here on how to request passes to cover the event.

In this new addition to our series of introductory animations, actor Edward James Olmos explains the role of telomeres in preventing the earliest stages in the development of cancer – a potent existing defence mechanism that SRF is working to reinforce.

SENS Research Foundation scientists Dr. Haroldo Silva and David Halvorsen, working on the "Alternative Lengthening of Telomeres" (ALT) pathway, collaborate with its discoverer Dr. Jeremy Henson to review its role in promoting some of the most deadly cancers.

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

SRF-funded researchers at Albert Einstein College of Medicine have published a new method for quantifying epigenetic mutations at the single cell level, enabling precise studies of aging-induced intercellular variation in the epigenome.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.

Check out all the latest news from SENS Research Foundation in our June newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The 2015 Summer Scholars Program has begun with 16 students at 7 prestigious institutions around the US and 1 in the UK. Check the SRF Education Blog to learn more about each scholar and the research s/he will be conducting.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, is among the five TED speakers interviewed by Guy Raz on the latest episode of NPR's lively TED Radio Hour: "The Fountain of Youth".

CCTV America’s Mark Niu sat down with SENS Research Foundation executives Mike Kope and Dr. Aubrey de Grey, to find out more about the SENS Research approach to preventing age-related disease.

SENS Research Foundation's Chief Science Officer, Dr. Aubrey de Grey, was recently interviewed regarding our work for the Joe Rogan Experience podcast.

Continuing our series of introductory scientific animations, narrator Edward James Olmos introduces the role of mitochondrial DNA damage in aging, and explains SRF’s preventative therapy for the diseases caused by such damage.

Our Rejuvenation Biotechnology 2015 Media Kit includes the latest conference brochure, regularly updated as we confirm additional world-class speakers. Members of the press can also find details here on how to request passes to cover the event.

In this new addition to our series of introductory animations, actor Edward James Olmos explains the role of telomeres in preventing the earliest stages in the development of cancer – a potent existing defence mechanism that SRF is working to reinforce.

SENS Research Foundation scientists Dr. Haroldo Silva and David Halvorsen, working on the "Alternative Lengthening of Telomeres" (ALT) pathway, collaborate with its discoverer Dr. Jeremy Henson to review its role in promoting some of the most deadly cancers.

In response to the many requests SENS Research Foundation has received from supporters, we are now able to accept donations of Bitcoin.

SRF-funded researchers at Albert Einstein College of Medicine have published a new method for quantifying epigenetic mutations at the single cell level, enabling precise studies of aging-induced intercellular variation in the epigenome.

SENS Research Foundation is delighted to release our 2014 Annual Report, containing detailed updates on all of our current research, outreach, and educational programs, plus a summary of our 2013 finances.

SRF-funded Oxford University PhD student David Brindley's paper, "The Global Intellectual Property Landscape of Induced Pluripotent Stem Cell Technologies", was published in the August issue of Nature Biotechnology.